Insulet Corp. Stock Slips 9.7%, Underperforms Peers

Dow Jones
2025/11/21

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Insulet Corp. slid 9.7% to $312.89 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.6% to 6,538.76 and Dow Jones Industrial Average falling 0.8% to 45,752.26.

The stock's fall snapped a two-day winning streak.

Insulet Corp. closed 11.5% below its 52-week high of $353.50, which the company reached on September 9th.

The stock underperformed when compared to some of its peers, as Eli Lilly & Co. fell 0.6% to $1,043.29, DexCom Inc. fell 2.2% to $58.42, and Johnson & Johnson rose 0.28% to $203.07.

Trading volume totaled 1.8 million, compared to the 50-day average of 594,827.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 20, 2025 16:33 ET (21:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10